Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 1, 2015
has subject area
- Diabetes Mellitus, Type 2 (MeSH)
- Diabetic Angiopathies (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Male (MeSH)
published in
- Diabetes Reviews Journal